Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
SN Compr Clin Med
.
2020;2(8):1017-1018.
doi: 10.1007/s42399-020-00375-0.
Epub 2020 Jun 26.
Authors
Francesco Ferrara
1
,
Francesco De Rosa
2
,
Antonio Vitiello
1
Affiliations
1
Usl Umbria 1, Perugia, Italy.
2
Campania Region, Naples, Italy.
PMID:
32838149
PMCID:
PMC7319216
DOI:
10.1007/s42399-020-00375-0
No abstract available
Keywords:
Depletive drugs; Immunomodulating; Myelin; SARS-CoV-2; Sclerosis.